drugset / Trial / NCT03775187

Expanded Access to Burosumab

NCT03775187

Expanded access Available Kyowa Kirin, Inc.

Summary

Individual patient expanded access requests may be considered for patients who have no other treatment options

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Background Burosumab Monoclonal antibody